These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1309230)

  • 1. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on biogenic amines and their acidic metabolites in brain and cerebrospinal fluid of rats.
    Elo HA; MacDonald E
    Arch Toxicol; 1989; 63(2):127-30. PubMed ID: 2471493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
    Ebinger G; Michotte Y; Herregodts P
    J Neurochem; 1987 Jun; 48(6):1725-9. PubMed ID: 3572399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrospinal fluid metabolism of biogenic amines in Huntington chorea].
    Loeb C; Roccatagliata G; Albano C; Lamedica G; Abbruzzese G; Canini S
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 119(2):333-42. PubMed ID: 137520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of indices of central dopaminergic functions in man.
    Bagdy G; Arató M; Baraczka K; Fekete MI
    Life Sci; 1983 Jun; 32(23):2667-76. PubMed ID: 6855463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias.
    Kaakkola S; Tuomainen P; Männistö PT; Palo J
    Acta Neurol Scand; 1993 Apr; 87(4):309-11. PubMed ID: 8503261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
    Frecska E; Perényi A; Bagdy G; Révai K
    Psychiatry Res; 1985 Nov; 16(3):221-6. PubMed ID: 2868474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
    Nikisch G; Baumann P; Kiessling B; Reinert M; Wiedemann G; Kehr J; Mathé AA; Piel M; Roesch F; Weisser H; Schneider P; Hertel A
    J Psychiatr Res; 2010 Sep; 44(12):754-9. PubMed ID: 20176367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
    Kärkelä J; Scheinin M
    J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta).
    Koutsilieri E; Götz ME; Sopper S; Stahl-Hennig C; Czub M; ter Meulen V; Riederer P
    Neuroreport; 1997 Dec; 8(17):3833-6. PubMed ID: 9427379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
    Goldstein DS; Holmes C; Sullivan P; Jinsmaa Y; Kopin IJ; Sharabi Y
    Parkinsonism Relat Disord; 2016 Oct; 31():79-86. PubMed ID: 27474472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease.
    Puginier E; Bharatiya R; Chagraoui A; Manem J; Cho YH; Garret M; De Deurwaerdère P
    Neurochem Int; 2019 Sep; 128():186-195. PubMed ID: 31054882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.
    García Ruiz PJ; Mena MA; Sanchez Bernardos V; Díaz Neira W; Gimenez Roldan S; Benitez J; García de Yebenes J
    Clin Neuropharmacol; 1995 Feb; 18(1):58-63. PubMed ID: 8665535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
    Bagdy G; Perényi A; Frecska E; Révai K; Papp Z; Fekete MI; Arató M
    Psychopharmacology (Berl); 1985; 85(1):62-4. PubMed ID: 2580329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of brain dopamine metabolism by tyrosine during immobilisation: an in vivo study using repeated cerebrospinal fluid sampling in conscious rats.
    Marcou M; Kennett GA; Curzon G
    J Neurochem; 1987 Apr; 48(4):1245-51. PubMed ID: 2434619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.